# Jeffrey Settleman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-settleman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,730 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 82 |
| i10-index | 148 |
| Last Known Institution | Enzo Life Sciences (United States) |
| OpenAlex ID | https://openalex.org/A5086227121 |
| ORCID iD | https://orcid.org/0000-0003-3569-6493 |
| Works | 424 |

## Researcher papers

- [Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer](https://scholariq.org/papers/anaplastic-lymphoma-kinase-inhibition-in-non-small-cell-lung-cancer/)
- [Systematic identification of genomic markers of drug sensitivity in cancer cells](https://scholariq.org/papers/systematic-identification-of-genomic-markers-of-drug-sensitivity-in-cancer-cells/)
- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells](https://scholariq.org/papers/detection-of-mutations-in-i-egfr-i-in-circulating-lung-cancer-cells/)
- [EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib](https://scholariq.org/papers/egfr-mediated-reactivation-of-mapk-signaling-contributes-to-insensitivity-of-i/)
- [First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations](https://scholariq.org/papers/first-line-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction](https://scholariq.org/papers/scffbw7-regulates-cellular-apoptosis-by-targeting-mcl1-for-ubiquitylation-and/)
- [Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models](https://scholariq.org/papers/synthetic-lethal-interaction-of-combined-bcl-xl-and-mek-inhibition-promotes/)
- [Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy](https://scholariq.org/papers/androgen-deprivation-causes-epithelial-mesenchymal-transition-in-the-prostate/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Researcher university

- [Enzo Life Sciences (United States)](https://scholariq.org/institutions/enzo-life-sciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.